Completed NA INTERVENTIONAL 2-arm NCT00293293

Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine

Sponsor: Masonic Cancer Center, University of Minnesota

Conditions Fallopian Tube Cancer Ovarian Cancer Peritoneal Primary Cancer

Interventions Standard chemotherapy healing touch hypnosis massage therapy

Updated 6 times since 2017 Last updated: Dec 3, 2017 Started: May 31, 2005 Primary completion: Apr 30, 2009 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Fallopian Tube Cancer and Ovarian Cancer, this trial is completed. The trial is conducted by Masonic Cancer Center, University of Minnesota and has accumulated 6 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jun 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2017 [monthly]

Completed NA

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Masonic Cancer Center, University of Minnesota
Randy Shaver Cancer Research Fund

Data source: Masonic Cancer Center, University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States